1. It costs a lot of money to study COVID-19 vaccine, which is unacceptable to pharmaceutical companies;
2. Giving up the intellectual property rights of vaccines in COVID-19 means no income;
3. If medical enterprises want to develop and feed so many people, giving up the intellectual property rights of vaccines in COVID-19 will put them under great pressure to survive.
The epidemic has a great impact on the world economy. With the slow and effective control of the epidemic, COVID-19 vaccine has played a very important role in it. After all, COVID-19 vaccine can stop the spread of most viruses, thus reducing the risk of many people. Pfizer CEO opposes giving up the intellectual property rights of COVID-19 vaccine, because the research of COVID-19 vaccine costs a lot of human and financial resources, which may not be earned at all, which is unacceptable to pharmaceutical companies; Giving up intellectual property rights in COVID-19 means that these pharmaceutical companies have no income. It is totally unrealistic for medical companies to develop and feed so many people.
First of all, it costs a lot of money to research COVID-19 vaccine, which is unacceptable to pharmaceutical companies.
Everyone should know that it takes a lot of energy, money and material resources to study a vaccine. It is totally unacceptable for these medical enterprises to invest so much and pay such a high price, and the intellectual property rights of vaccines in COVID-19 are completely free.
Second, giving up the intellectual property rights of vaccines in COVID-19 means that they have no income.
When the intellectual property rights of vaccines in COVID-19 are abandoned, it means that every country can produce vaccines, which leads to the loss of income of medical enterprises. This is the main reason why Pfizer CEO opposes giving up the intellectual property rights of COVID-19 vaccine.
Third, developing medical enterprises to feed so many people means increasing the pressure of survival.
Every enterprise wants to develop and support so many employees, but it can't get any return by investing huge amounts of money, which will lead to increasing pressure on the survival of enterprises and make employees feel dissatisfied. It is very unfavorable for medical companies to give up the intellectual property rights of vaccines in COVID-19, which is also the reason for their opposition.